Showing results (1511-1520 of 2,234) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|June 30, 2007
Flt3 ligand delivered in a pluronic formulation prolongs the survival of mice with orthotopic pancreatic adenocarcinomaAbdelkader E Ashour, Hēth R Turnquist, Nicole Burns, et al.Cancer Biotherapy & Radiopharmaceuticals|June 30, 2007
Optimization of equipment and methodology for whole body activity retention measurements in children undergoing targeted radionuclide therapySarah J Chittenden, Brenda E Pratt, Kay Pomeroy, et al.Cancer Biotherapy & Radiopharmaceuticals|June 30, 2007
Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factorsJasna Mihailovic, Ljubomir Stefanovic, Milica MalesevicCancer Biotherapy & Radiopharmaceuticals|June 30, 2007
Radioiodine treatment of Plummer and multinodular toxic and nontoxic goiter disease by the first approximation dosimetry methodMatteo Zingrillo, Nicoletta Urbano, Vincenzo Suriano, et al.Cancer Biotherapy & Radiopharmaceuticals|June 30, 2007
Translation of dosimetric results of preclinical radionuclide therapy to clinical situations: influence of photon irradiationHelena Uusijärvi, Peter Bernhardt, Eva Forssell-AronssonCancer Biotherapy & Radiopharmaceuticals|June 30, 2007
Semiautomated thoracic and abdominal computed tomography segmentation using the belief functions theory: application to 3D internal dosimetryArnaud Dieudonné, Peng Zhang, Patrick Vannoorenberghe, et al.Cancer Biotherapy & Radiopharmaceuticals|June 30, 2007
The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptakeMurat Tuncel, Didem Aydin, Elif Yaman, et al.Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Evaluation of the binding of radiolabeled rituximab to CD20-positive lymphoma cells: an in vitro feasibility study concerning low-dose-rate radioimmunotherapy with the alpha-emitter 227ThKatrine B Melhus, Roy H Larsen, Trond Stokke, et al.Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Radiotherapy of CD45-expressing Daudi tumors in nude mice with yttrium-90-labeled, PEGylated anti-CD45 antibodyDaniel A Vallera, Andy R Sicheneder, Elizabeth P Taras, et al.Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Extraperitoneal leakage as a possible explanation for failure of one-time intraperitoneal treatment in ovarian cancerAngèle L M Oei, Leon F A G Massuger, Wim J G OyenPageof 224